α1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?

被引：14

作者：

Roehrborn, Claus G. ^{[1
]}

Cruz, Francisco ^{[2
,3
]}

Fusco, Ferdinando ^{[4
]}

机构：

[1] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA

[2] Hosp Sao Joao, Dept Urol, Oporto, Portugal

[3] Univ Naples Federico II, Dept Urol, Naples, Italy

[4] Univ Porto, Fac Med, Dept Renal Urol & Infect Dis, Oporto, Portugal

来源：

ADVANCES IN THERAPY | 2017年 / 33卷 / 12期

关键词：

Alpha-blockers; Silodosin; Urology; INDIVIDUAL PATIENT DATA; ALPHA(1)-ADRENOCEPTOR ANTAGONISTS; HYPERPLASIA BPH; DOUBLE-BLIND; ALPHA(1A)-ADRENOCEPTOR-SELECTIVE ANTAGONIST; REGISTRATIONAL TRIALS; NOCTURNAL POLYURIA; METAANALYSIS; EFFICACY; PLACEBO;

D O I：

10.1007/s12325-016-0423-5

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Available alpha 1-blockers (ABs) have different profiles of receptor selectivity. Silodosin exhibits the highest selectivity for the alpha(1A) adrenergic receptor. This pharmacological feature couples with a singular urodynamic and clinical profile. The magnitude of bladder outlet obstruction improvement in patients receiving silodosin is higher if compared to other ABs. From a clinical point of view, current evidence suggests an advantage in favor of silodosin in terms of nocturia improvement and cardiovascular safety. The incidence of ejaculatory dysfunction with silodosin is higher compared to other Abs.

引用

页码：2110 / 2121

页数：12

共 39 条

[11]

Kaplan Steven A, 2009, Rev Urol, V11, pS14

[12] Silodosin, a new α1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia:: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men [J].

Kawabe, Kazuki ;

Yoshida, Masaki ;

Homma, Yukio .

BJU INTERNATIONAL, 2006, 98 (05) :1019-1024

[13] The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study [J].

Kim, Young Won ;

Park, Jinsung ;

Chung, Hong ;

Kim, Hong-Wook ;

Kim, Hyung Joon ;

Jung, Jae Hung ;

Kim, Won Tae .

INTERNATIONAL NEUROUROLOGY JOURNAL, 2015, 19 (03) :190-196

[14] A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia [J].

Kirby, RS ;

Andersen, M ;

Gratzke, P ;

Dahlstrand, C ;

Hoye, K .

BJU INTERNATIONAL, 2001, 87 (03) :192-200

[15] Nocturia and Quality of Life: Results from the Boston Area Community Health Survey [J].

Kupelian, Varant ;

Wei, John T. ;

O'Leary, Michael P. ;

Norgaard, Jens Peter ;

Rosen, Raymond C. ;

McKinlay, John B. .

EUROPEAN UROLOGY, 2012, 61 (01) :78-84

[16]

Lepor Herbert, 2009, Rev Urol, V11, pS9

[17] Role of the newer alpha1-adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms [J].

Lowe, FC .

CLINICAL THERAPEUTICS, 2004, 26 (11) :1701-1713

[18] National Trends in Surgical Therapy for Benign Prostatic Hyperplasia in the United States (2000-2008) [J].

Malaeb, Bahaa S. ;

Yu, Xinhua ;

McBean, A. Marshall ;

Elliott, Sean P. .

UROLOGY, 2012, 79 (05) :1111-1116

[19] Rapid Efficacy of the Highly Selective α1A-Adrenoceptor Antagonist Silodosin in Men With Signs and Symptoms of Benign Prostatic Hyperplasia: Pooled Results of 2 Phase 3 Studies [J].

Marks, Leonard S. ;

Gittelman, Marc C. ;

Hill, Lawrence A. ;

Volinn, Weining ;

Hoel, Gary .

JOURNAL OF UROLOGY, 2009, 181 (06) :2634-2640

[20] Efficacy of Silodosin for Relieving Benign Prostatic Obstruction: Prospective Pressure Flow Study [J].

Matsukawa, Yoshihisa ;

Gotoh, Momokazu ;

Komatsu, Tomonori ;

Funahashi, Yasuhito ;

Sassa, Naoto ;

Hattori, Ryohei .

JOURNAL OF UROLOGY, 2009, 182 (06) :2831-2835

← 1 2 3 4 →